Al Sharabati Miral, Sabouni Rana, Husseini Ghaleb A
Department of Chemical Engineering, American University of Sharjah, Sharjah P.O. Box 26666, United Arab Emirates.
The Material Science and Engineering Program, College of Arts and Sciences, American University of Sharjah, Sharjah P.O. BOX 26666, United Arab Emirates.
Nanomaterials (Basel). 2022 Jan 16;12(2):277. doi: 10.3390/nano12020277.
Metal-organic frameworks (MOFs) are a novel class of porous hybrid organic-inorganic materials that have attracted increasing attention over the past decade. MOFs can be used in chemical engineering, materials science, and chemistry applications. Recently, these structures have been thoroughly studied as promising platforms for biomedical applications. Due to their unique physical and chemical properties, they are regarded as promising candidates for disease diagnosis and drug delivery. Their well-defined structure, high porosity, tunable frameworks, wide range of pore shapes, ultrahigh surface area, relatively low toxicity, and easy chemical functionalization have made them the focus of extensive research. This review highlights the up-to-date progress of MOFs as potential platforms for disease diagnosis and drug delivery for a wide range of diseases such as cancer, diabetes, neurological disorders, and ocular diseases. A brief description of the synthesis methods of MOFs is first presented. Various examples of MOF-based sensors and DDSs are introduced for the different diseases. Finally, the challenges and perspectives are discussed to provide context for the future development of MOFs as efficient platforms for disease diagnosis and drug delivery systems.
金属有机框架(MOFs)是一类新型的多孔有机-无机杂化材料,在过去十年中受到了越来越多的关注。MOFs可用于化学工程、材料科学和化学应用。最近,这些结构作为生物医学应用的有前景的平台受到了深入研究。由于其独特的物理和化学性质,它们被视为疾病诊断和药物递送的有前途的候选者。它们明确的结构、高孔隙率、可调节的框架、广泛的孔形状、超高的表面积、相对较低的毒性以及易于化学功能化,使其成为广泛研究的焦点。本综述重点介绍了MOFs作为多种疾病(如癌症、糖尿病、神经系统疾病和眼部疾病)的疾病诊断和药物递送潜在平台的最新进展。首先简要介绍了MOFs的合成方法。针对不同疾病介绍了各种基于MOF的传感器和药物递送系统的实例。最后,讨论了挑战和前景,为MOFs作为疾病诊断和药物递送系统的高效平台的未来发展提供背景。
Nanomaterials (Basel). 2022-1-16
Anticancer Agents Med Chem. 2021
Nanomicro Lett. 2020-5-2
Curr Med Chem. 2020
Acta Pharm Sin B. 2021-8
Adv Mater. 2017-3-29
ACS Biomater Sci Eng. 2023-8-14
Acc Chem Res. 2016-3-15
Biol Trace Elem Res. 2025-6-24
ACS Appl Mater Interfaces. 2025-4-9
Small. 2025-4
Natl Sci Rev. 2019-11-5
Acta Pharm Sin B. 2021-8
Sensors (Basel). 2021-7-31
Nanomicro Lett. 2020-5-2
Anticancer Agents Med Chem. 2021
J Biomed Nanotechnol. 2020-9-1